Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by KnowledgeBaseon Dec 04, 2018 1:17pm
132 Views
Post# 29062256

A reminder!

A reminder!
  • Obtained the Drug Establishment License for the manufacturing of PPP001;
  • Completed the Type B and C meetings with the U.S. FDA;
  • Made a bid to acquire Panag Pharma Inc. and grow its intellectual property;
  • Advanced the timing of its filing for PPP001 in Europe;
  • Signed two distribution and sales agreements with pharmaceutical companies based in Israel and Portugal for our PPP001 drug product; 
  • Successfully setup a growing Hemp Energy Drink business and shortly after ordered 1.7 million cans for sales;
  • Hired senior pharmaceutical industry talent with depth of experience to oversee operations in a timely, systematic way; and
  • Implemented plans to ensure supply of cannabis raw materials thus avoiding back orders on drug or commercial products. 

Dr. Chamberland further stated, “Tetra has never been in a stronger position in its history and looks forward to continued execution of its strategy.”

<< Previous
Bullboard Posts
Next >>